The wound
closure products market is growing due to increasing
geriatric population, increase in volume of surgeries and growing road accident
cases across the globe.
Among the different type of wound closure
products, the hemostats segment is expected to witness the fastest growth
during the forecast period. Among the various applications, the cardiovascular
segment accounted for the largest share in the global market in 2015, and it is
expected to witness 6.9% CAGR during 2016 – 2022.
In 2015, North America held the largest
share in the global wound closure market whereas, Asia-Pacific market is
expected to witness fastest growth, with a CAGR of 7.0% during the period 2016–
2022.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/wound-closure-products-market/report-sample
Wound closure products are designed to join
the exposed edges of a wound together, which helps in faster healing of wound.
The main purpose of using these products is to prevent blood loss, reduce
recovery time and prevention from infectious agents. The various types of wound
closure products include sutures, hemostats, surgical staples, adhesive and
tissue sealants, and wound closure strips. They are commonly used for the
treatment of injuries, lacerations, during and after surgical procedures, and
to treat wounds, burn cases and ulcers in humans.
Absorbable wound closure products are
assimilated by the body and non-absorbable wound closure products are removed
after utilization. Absorbable wound closure products also reduce the scaring of
tissue produced during the healing process. Various synthetic materials, such
as nylon, prolene, medical grade steel, polyester, chromium and titanium alloys
are used for their manufacturing. In addition, biomaterial, such as fibrin,
collagen, gelatin and thrombin are also used for manufacturing of wound closure
products.
Some of the key companies operating in the global wound closure products market include 3M Company, Medtronic plc, Smith and Nephew plc, CryoLife Inc., DeRoyal Industries Inc., Pfizer Inc., Derma Sciences Inc., Johnson and Johnson, B. Braun Melsungen AG and Baxter International Inc.
No comments:
Post a Comment